The Value of S100A9, ORM2, SOD1 and IL1F6 in Evaluating the Prognosis of Secondary Pulmonary Tuberculosis

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2018
This article has no abstract
Epistemonikos ID: 484588c9a200c0ef273e3bd06ba8d5e2f836bbe4
First added on: Apr 07, 2025